DIAGNOSTIC PROBLEMS OF MUCOVISCIDOSIS AND WAYS OF SOLUTION IN RUSSIA

Mucoviscidosis is a monogenic autosomal recessive caused by the CFTR gene mutations and characterized by pronounced genetic heterogeneity and clinical polymorphism, which emphasizes the need in comprehensive diagnosis and molecular-genetic verification of the final diagnosis. Quality and duration of a mucoviscidosis patient depend on early diagnosis and timely adequate therapy. The article presents mucoviscidosis diagnostic methods and protocols and capabilities of the modern molecular-genetic pathological diagnosis; a review of DNA diagnostic sets has been performed. As sets of some of the genes typical to the Russian population have not been registered in the Russian Federation, mutations in 20% of the patients cannot be specified. In order to solve this problem it is necessary to develop DNA diagnostic sets specific for the Russian Federation, ensure genetic diagnosis of the disease, including sequencing methods at the expense of the federal budget, increase the amount of information and improve quality of teaching this discipline to  students of medial universities and at postgraduate courses for appropriate specialists.

1. Hodson M., Geddes D., Bush A. Cystic fibrosis. London, Hodder Arnold, 2007. P. 503.

2. Tatochenko V.K., Rachinskii S.V., Volkov I.K., Fedorov A.M. Prakticheskaya pul'monologiya detskogo vozrasta: Spravochnik [Practical Pediatric Pulmonology: Handbook]. Moscow, 2006. 250 p.

3. Kapranov N.I., Kashirskaya N.Yu. Mukovistsidoz. Sovremennye dostizheniya i aktual'nye problemy. Metod. rekomendatsii. Izd. 4-e [Cystic Fibrosis. Modern Achievements and Current Problems. Method. Recommendations. 4th edition]. Moscow, 2011. 124 p.

4. Simonova O.I. Combined therapy of children with cystic fibrosis: Recommendations for the pediatrician. Pediatricheskaya farmakologiya = Pediatric pharmacology. 2006; 3 (6): 44–50.

5. Baranov A.A., Volodin N.N., Samsygina G.A. Ratsional'naya farmakoterapiya detskikh zabolevanii. T. 1 [Rational Pharmacotherapy of Childhood Diseases. Volume 1]. Moscow, Litterra, 2007. 2400 p.

6. Gorinova Yu.V., Simonova O.I., Tomilova A.Yu., Roslavtseva E.A. Algorithm posindromnoy complex therapy in cystic fibrosis in children: a modern approach. Voprosy sovremennoi pediatrii = Current Pediatrics. 2013; 12 (5): 30–38.

7. Sinaasappel M., Stern M., Littlewood J., Wolfe S., Steinkamp G., Heijerman H.G.M., Robberecht E., Doring G. Nutrition in patients with cystic fibrosis: a European Consensus. Journal of Cystic Fibrosis. 2002; 1 (2): 51–75.

8. Tsaregorodtsev A.D., Kapranov N.I., Kashirskaya N.Yu., Tolstova V.D. Mukovistsidoz. Rebenok i lekarstvo. Spravochnoe posobie dlya detskikh vrachei (izd. vtoroe) [Cystic Fibrosis. Child and Medicine. Handbook for Pediatricians. 2nd edition]. Moscow, Overlei, 2008. 608 p.

9. Wilschanski M. Novel Therapeutic Approaches for Cystic Fibrosis. Discov Med. 2013 Feb; 15 (81): 127–33.

10. Canadian Cystic Fibrosis Patient Data Registry Report. Canadian Cystic Fibrosis Foundation. 2010. Р. 4.

11. Dodge J.A., Lewis P.A., Stanton M., Wilsher J. Cystic fibrosis mortality and survival in the UK: 1947–2003. Eur Respir J. 2007; 29: 522–526.

12. Wolfenden L.L., Schechter M.S. Genetic and non-genetic determinants of outcomes in cystic fibrosis. Paediatr Respir Rev. 2009; 10 (1): 32–36.

13. Krasovskii S.A.,Chernyak A.V., Nikonova V.S., Kondrat'eva E.I., Kashirskaya N.Yu., Voronkova A.Yu., Amelina E.L., Kapranov N.I., Sherman V.D., Shabalova L.A., Samoilenko V.A., Usacheva M.V., Semykin S.Yu., Simonova O.I., Avakyan L.V., Gorinova Yu.V., Kusova Z.A. Vyzhivaemost' bol'nykh mukovistsidozom v Moskovskom regione za period 2003–2012 gg. Sbornik tezisov XI Natsional'nogo kongressa po mukovistsidozu «Mukovistsidoz u detei i vzroslykh. Vzglyad v budushchee», 24–25 iyunya [Survival of Patients with Cystic Fibrosis in the Moscow Region for the Period of 2003-2012 gg. Book of Abstracts of 11th National Congress of Cystic Fibrosis "Cystic Fibrosis in Children and Adults. Looking into the Future", June 24-25]. Moscow, 2013. P. 53–54.

14. Krasovskii S.A., Chernyak A.V., Amelina E.L., Nikonova V.S., Voronkova A.Yu., Samoilenko V.A., Naumenko Zh.K., Kashirskaya N.Yu., Kapranov N.I., Sherman V.D., Shabalova L.A., Chistyakova V.P., Simonova O.I., Semykin S.Yu., Gorinova Yu.V., Avakyan L.V., Petrova P.N., Kusova Z.A., Usacheva M.V., Samsonova M.V. et al. The dynamics of survival of cystic fibrosis patients in Moscow and the Moscow region for the periods 1992-2001 and 2002-2011. Pul'monologiya = Pulmonology. 2012; 3: 79–87.

15. Kapranov N.I., Kashirskaya N.Yu. Problems of organization and improving health and social care for patients with cystic fibrosis in Russia at the present stage. Lechebnoe delo = Medical care. 2010; 2: 12–17.

16. Amelina E.L., Chernyak A.V., Chernyaev A.L. AL Cystic fibrosis: the definition of life expectancy. Pul'monologiya = Pulmonology. 2001; 3: 61–64.

17. Krasovskii S.A., Amelina E.L., Chernyak A.V. et al. The role of the register of the Moscow region in the management of patients with cystic fibrosis. Pul'monologiya = Pulmonology. 2013; 2: 27–32.

18. Mehtaa G., Macek M., Jr., Mehtaa A. Cystic Fibrosis across Europe: EuroCare CF analysis of demographic data from 35 countries. Journal of Cystic Fibrosis. 2010; 9: S5–21.

19. Asherova I.K. Snizhenie tyazhesti techeniya zabolevaniya, povyshenie vyzhivaemosti i kachestva zhizni bol'nykh mukovistsidozom na osnove sovershenstvovaniya mezhdistsiplinarnoi spetsializirovannoi pomoshchi. Avtoref. dis. ...dokt. med. nauk [Reduction in the severity of the disease, improving survival and quality of life in patients with cystic fibrosis based on improving interdisciplinary specialized care. Author’s abstract]. Moscow, 2012.

20. Gembitskaya T.E., Chermenskii A.G., Boitsova E.V. Cystic fibrosis today: Achievements and Challenges, perspectives etiopathogenic therapy. Vrach = The Doctor. 2012; 2: 5–8.

21. Rowe S.M., Miller S., Sorscher E.J. Mechanisms of disease Cystic fibrosis. N Engl J Med. 2005; 352: 1992–2001.

22. Kusova Z.A., Kashirskaya N.Yu., Kapranov N.I. Features mass newborn screening for cystic fibrosis. Russkii meditsinskii zhurnal (Chelovek i lekarstvo. Chast' 1) = Russian Medical Journal (Man and medicine. Part 1). 2010; 18 (5): 265–270.

23. Classification of cystic fibrosis and related disorders. Report of a Joint Working Group of WHO/ICF(M)A/ECFS/ECFTN, World Health Organization. 2000. J Cyst Fibros. 2002; 1: 5–8.

24. Bombieri С., Claustres M., De Boek K. et al. Recommendations for classification of diseases as CF-related disorders. J of Cystic Fibrosis. 2011; 10 (2): S86–102.

25. Castellani C., Cuppens H., Macek M., Jr. et al. Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibr. 2008; 8: 179–196.

26. Mishra A., Greaves R., Massie J. The relevance of sweat testing for the diagnosis of cystic fibrosis in the genomic era. Clin Biochem Rev. 2005; 26: 135–153.

27. Ahmed N., Corey M., Forstner G. et al. Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas. Gut. 2003; 52: 1152–1164.

28. Koch C., Cuppens H., Rainisio M. et al. Investigators of the European Register of Cystic Fibrosis (ERCF): comparison of major disease manifestations between patients with different classes of mutations. Pediatr Pulmonol. 2001; 31 (1): 1–12.

29. Bombieri С., Benetazzo M., Saccomani A. et al. Complete mutational screening of the CFTR gene in 120 patients with pulmonary disease. Hum Genet. 1998; 103: 718–722.

30. Ziedalski T.M., Kao P.N., Henig N.R. et al. Prospective analysis of cystic fibrosis transmembrane conductance regulator mutations in adults with bronchiectasis or pulmonary nontuberculous mycobacterial infection. Chest. 2006; 130 (4): 995–1002.

31. Tzetis M., Efthymiadou A., Strofalis S. et al. CFTR gene mutations ― including three novel nucleotide substitutions – and haplotype background in patients with asthma, disseminated bronchiectasis and chronic obstructive pulmonary disease. Hum Genet. 2001; 108: 216–221.

32. Mennicke K., Kligenberg R.D., Bals-Pratsch M. et al. Rational approach to genetic testing of cystic fibrosis (CF) in infertile men. Andrologia. 2005; 37: 1–9.

33. Petrova N.V. Molekulyarno-geneticheskie i kliniko-genotipicheskie osobennosti mukovistsidoza v rossiiskikh populyatsiyakh. Avtoref. dis. ...dokt. biol. nauk [Molecular genetic, clinical and genotypic characteristics of cystic fibrosis in the Russian population. Author’s abstract]. Moscow, 2009.

34. Rosenstein B.J., Cutting G.R. Cystic fibrosis Foundation Consensus Panel. The diagnosis of cystic fibrosis: a consensus statement. J Pediatr. 1998; 132: 589–595.

35. De Boeck K., Wilschanski M., Castellani C., Taylor C., Cuppens H., Dodge J., Sinaasappel M. Cystic fibrosis: terminology and diagnostic algorithms. Thorax. 2006; 61: 627–635.

36. Simonova O.I., Gorinova Yu.V., Lazareva A.V., Katosova L.K., Burkina N.I., Chernevich V.P. Solving the problem of chronic Pseudomonas aeruginosa infection in children with cystic fibrosis. Voprosy sovremennoi pediatrii = Current Pediatrics. 2014; 13 (1): 66–73.

37. Simonova O.I., Gorinova Yu.V., Lazareva A.V. Initial seeding Pseudomonas aeruginosa in cystic fibrosis - not a sentence to the patient. Rossiiskii pediatricheskii zhurnal = Russian Journal of Pediatrics. 2009; 4: 60–63.

38. Lazareva A.V., Lominadze G.G., Simonova O.I., Kryzhanovskaya O.A., Katosova L.K. Dinamika etiologicheskogo spektra vozbuditelei bronkholegochnogo vospaleniya u detei s mukovistsidozom v period 2010–2012 gg. Sbornik tezisov XI Natsional'nogo kongressa «Mukovistsidoz u detei i vzroslykh. Vzglyad v budushchee», 24–25 maya [The Dynamics of the Etiological Spectrum of Pathogens of Bronchopulmonary Inflammation in Children with Cystic Fibrosis in the Period 2010-2012. Book of Abstracts of 11th National Congress of Cystic Fibrosis "Cystic Fibrosis in Children and Adults. Looking into the Future ", May 24-25]. Moscow, 2013. P. 54–55.

39. Lazareva A.V., Katosova L.K., Simonova O.I. Cyto-microscopic sputum and tracheal aspirates obtained from children with bronchopulmonary diseases and cystic fibrosis, to assess their suitability for the study of culture. Voprosy diagnostiki v pediatrii = Diagnostics in pediatrics. 2009; 1 (4): 32–35

40. Kerem E., Conway S., Elborn S., Heijerman H. Standards of care for patients with cystic fibrosis: a European consensus. J Cyst Fibros. 2005; 4: 7–26.

41. Farrell P.M., Rosenstein B.J., White T.B., Accurso F.J., Castellani C., Cutting G.R. et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr. 2008; 153: S4–14.

42. Sherman V.D., Kashirskaya N.Yu., Kapranov N.I. Neonatal'nyi skrining na mukovistsidoz. V kn.: Mukovistsidoz. Pod red. N.I. Kapranova i N.Yu. Kashirskoi [Neonatal Screening for Cystic Fibrosis. In: Cystic Fibrosis. Edited by N.I. Kapranov and N.Yu. Kashirskaya]. Moscow, Medpraktika-M, 2014. P. 80–99, 100–107.

43. Simonova O.I., Tomilova A.Yu., Gorinova Yu.V., Surkov A.N., Roslavtseva E.A., Namazova-Baranova L.S. Mukovistsidoz. Bolezni detskogo vozrasta ot A do Ya. T. 5 [Cystic Fibrosis. Childhood Diseases from A to Z. Volume 5]. Moscow, 2014. 89 p.

44. Kusova Z.A., Kashirskaya N.Yu., Kapranov N.I. Neonatal screening for cystic fibrosis. Meditsinskaya genetika = Medical Genetics. 2010; 9: 36–40.

45. Kusova Z.A. Effektivnost' programmy massovogo obsledovaniya novorozhdennykh na mukovistsidoz. Avtoref. dis. ...kand. med. nauk [Effectiveness of the program of screening newborns for cystic fibrosis. Author’s abstract]. Moscow, 2011.

46. Krasovskii S.A., Nikonova V.S., Kashirskaya N.Yu., Kondrat'eva E.I., Chernyak A.V., Kapranov N.I., Amelina E.L., Sherman V.D., Samoilenko V.A., Voronkova A.Yu., Shabalova L.A., Simonova O.I., Usacheva M.V., Chernikov V.V. Clinico-genetic, microbiological and functional characteristics of patients with cystic fibrosis, living in Moscow and the Moscow region. Voprosy sovremennoi pediatrii = Current Pediatrics. 2013; 12 (1): 17–23.

47. Cystic Fibrosis Genotyping Assay for Use with the ABI PRISM 3100/3100-Avant Genetic Analyzers. USA: Celera 1401 Harbor Bay Pkwy Alameda. CA 94502 04/2007. 2007. Р. 68.

48. Available at: http://www.rusnanonet.ru/news/101009/Accessed July 3, 2014.

49. Sherman V.D., Kashirskaya N.Yu., Kapranov N.I. Modern diagnostic algorithm of cystic fibrosis. Pediatriya. Zhurnal im. G.N. Speranskogo = PEDIATRIYA – MOSCOW. 2014; 93 (4): 68–74.

50. Smirnov A.M., Zaitseva M.A., Pavlov A.E. Prospects for application of the method in clinical practice NGS newborn screening. Rossiiskii vestnik perinatologii i pediatrii = Russian bulletin of perinatology and pediatrics. 2013; 2: 37–40.